ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 197 filers reported holding ARIAD PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.15 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $3,157,000 | -19.2% | 253,807 | -11.1% | 0.01% | -25.0% |
Q3 2016 | $3,909,000 | +50.1% | 285,532 | -19.0% | 0.01% | +50.0% |
Q2 2016 | $2,605,000 | +7.7% | 352,467 | -6.9% | 0.01% | 0.0% |
Q1 2016 | $2,419,000 | -35.1% | 378,568 | -36.5% | 0.01% | -27.3% |
Q4 2015 | $3,728,000 | -15.3% | 596,448 | -20.9% | 0.01% | -21.4% |
Q3 2015 | $4,401,000 | -37.1% | 753,679 | -10.9% | 0.01% | -17.6% |
Q2 2015 | $6,993,000 | +19.1% | 845,615 | +18.7% | 0.02% | +21.4% |
Q1 2015 | $5,870,000 | +49.5% | 712,320 | +24.7% | 0.01% | +40.0% |
Q4 2014 | $3,926,000 | +30.0% | 571,443 | +2.2% | 0.01% | +42.9% |
Q3 2014 | $3,021,000 | -8.4% | 559,392 | +8.1% | 0.01% | -12.5% |
Q2 2014 | $3,297,000 | -39.6% | 517,570 | -23.6% | 0.01% | -50.0% |
Q1 2014 | $5,459,000 | +44.0% | 677,369 | +21.8% | 0.02% | +33.3% |
Q4 2013 | $3,792,000 | -43.0% | 556,030 | +53.8% | 0.01% | -50.0% |
Q3 2013 | $6,651,000 | +12.9% | 361,471 | +7.3% | 0.02% | -4.0% |
Q2 2013 | $5,890,000 | – | 336,767 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 12,850,000 | $69,390,000 | 26.80% |
Opaleye Management Inc. | 1,500,000 | $8,100,000,000 | 6.31% |
Camber Capital Management LP | 6,000,000 | $32,400,000 | 3.04% |
Ghost Tree Capital, LLC | 700,000 | $3,780,000 | 2.05% |
Granite Point Capital Management, L.P. | 700,000 | $3,780,000 | 1.88% |
Duquesne Family Office | 1,645,000 | $8,883,000 | 1.09% |
Geduld E E | 272,200 | $1,470,000 | 1.04% |
Elk Creek Partners, LLC | 659,232 | $3,560,000 | 0.93% |
Palo Alto Investors LP | 2,231,717 | $12,051,000 | 0.90% |
HighVista Strategies LLC | 1,200,000 | $6,480,000 | 0.87% |